Author:
De Ruysscher Dirk,Dehing Cary,Yu Shipeng,Wanders Rinus,Öllers Michel,Dingemans Anne-Marie C.,Bootsma Gerben,Hochstenbag Monique,Geraedts Wiel,Pitz Cordula,Simons Jean,Boersma Liesbeth,Borger Jacques,Dekker Andre,Lambin Philippe
Subject
Radiology, Nuclear Medicine and imaging,Oncology,Hematology
Reference36 articles.
1. Curran W, Scott C, Langer C, et al. Long-term benefit is observed in a phase III comparison of sequential vs concurrent chemo-radiation for patients with unresected stage III nsclc: RTOG 9410 [Abstract]. Proc ASCO 2003:2499.
2. Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer;Furuse;J Clin Oncol,1999
3. Continuous, hyperfractionated, accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small cell lung cancer: mature data from the randomised multi-center trial;Saunders;Radiother Oncol,1999
4. Final results of phase III trial in regionally advanced unresectable non-small cell lung cancer: radiation therapy oncology group, eastern cooperative oncology group, and southwest oncology group;Sause;Chest,2000
5. Final report of the 70.2-Gy and 75.6-Gy dose levels of a phase I dose escalation study using three-dimensional conformal radiotherapy in the treatment of inoperable non-small cell lung cancer;Rosenzweig;Cancer J,2000
Cited by
36 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献